Verteporfin
Click to View Image
C41H42N4O8 718.79
23H,25H-Benzo[b]porphine-9,13-dipropanoic acid,18-ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl-,monomethyl ester,trans-.
(±)-trans-3,4-Dicarboxy-4,4a-dihydro-4a,8,14,19-tetramethyl-18-vinyl-23H,25H-benzo[b]porphine-9,13-dipropanoic acid,3,4,9-trimethyl ester mixture with (±)-trans-3,4-dicarboxy-4,4a-dihydro-4a,8,14,19-tetramethyl-18-vinyl-23H,25H-benzo[b]porphine-9,13-dipropionic acid,3,4,13-trimethyl ester [129497-78-5].
»Verteporfin contains not less than 94.0percent and not more than 102.0percent of C41H42N4O8,calculated on the anhydrous basis.
Caution—Verteporfin is a light-activated drug used in photodynamic therapy.Care should be taken to avoid contact with eyes and skin.
Packaging and storage— Preserve in tight containers,and store in a freezer.
Identification—
A: Infrared Absorption á197Mñ.
B: The retention times of the two major peaks in the chromatogram of the Assay preparationcorrespond to those in the chromatogram of the Standard preparation,as obtained in the Assay.
Microbial limits á61ñ The total aerobic microbial count does not exceed 100cfu per g.
Bacterial endotoxins á85ñ: not more than 0.5USP Endotoxin Unit per mg of verteporfin.
Water,Method Ic á921ñ: not more than 1.4%.
Residue on ignition á281ñ: not more than 0.2%.
Heavy metals,Method Iá231ñ: not more than 0.002%.
Related compounds—
Solution A,Solution B,and Mobile phase— Proceed as directed in the Assay.
Test solution— Prepare as directed for Assay preparationin the Assay.
Chromatographic system— Proceed as directed in the Assay.To evaluate the system suitability requirements,use the Standard preparationprepared as directed in the Assay.
Procedure— Inject a volume (about 20µL)of the Test solutioninto the chromatograph,record the chromatograms,and measure the peak responses.Calculate the percentage of each related compound in the portion of Verteporfin taken by the formula:
100(ri/rs),
in which riis the individual peak response of each related compound;and rsis the sum of the responses of all the peaks.Not more than 0.6%of the peak having a retention time of about 0.56relative to that of the first verteporfin isomer peak is found;not more than 0.8%of any other individual related compound is found;and the sum of all impurities is not more than 4.0%.
Limit of methylene chloride— Use the procedure for Method 1under Organic Volatile Impurities á467ñ,with the following exceptions.
Standard solution: 50µg of methylene chloride per mLin dimethylformamide.
Test solution: 10mg of Verteporfin per mLin dimethylformamide.
Limit: not more than 5000µg per g of Verteporfin (0.5%).
Assay—
Solution A— Prepare a filtered and degassed mixture of 1%(w/v)aqueous ammonium sulfate,acetonitrile,glacial acetic acid,and 3.6Msulfuric acid (10:10:1:0.027).
Solution B— Prepare a filtered and degassed mixture of 1%(w/v)aqueous ammonium sulfate,tetrahydrofuran,glacial acetic acid,and 3.6Msulfuric acid (10:10:1:0.034).
Mobile phase— Use variable mixtures of Solution Aand Solution Bas directed for Chromatographic system.Make adjustments if necessary (see System Suitabilityunder Chromatography á621ñ).
Standard preparation— To a suitable volumetric flask,transfer an accurately weighed quantity of USP Verteporfin RSsufficient to make a 0.25mg per mLsolution.Add a volume of a mixture of acetonitrile and tetrahydrofuran (1:1)equivalent to 60%of the flask volume,and dissolve.Dilute with water to volume,and mix.[NOTE—Protect the solution from light.]
Assay preparation— Transfer about 25mg of Verteporfin,accurately weighed,to a 100-mLvolumetric flask.Add 60mLof a mixture of acetonitrile and tetrahydrofuran (1:1),and dissolve.Dilute with water to volume,and mix.[NOTE—Protect the solution from light.]
Chromatographic system(see Chromatography á621ñ)— The liquid chromatograph is equipped with a 410-nm detector and a 4.6-mm ×25-cm column that contains packing L1.The flow rate is 1.5mLper minute.The column temperature is maintained at 30.The chromatograph is programmed as follows.
Time
(minutes)
Solution A
(%)
Solution B
(%)
Elution
0–60 80 20 isocratic
60–90 80®60 20®40 linear gradient
90–91 60 40 isocratic
91–120 60®30 40®70 linear gradient
120–121 30 70 isocratic
121–125 30®0 70®100 linear gradient
125–137 0 100 isocratic
137–140 0®80 100®20 linear gradient
140–150 80 20 isocratic
Chromatograph the Standard preparation,and record the peak responses as directed for Procedure:the resolution,R,between the two verteporfin peaks is not less than 2.5;the tailing factor is not more than 1.3;and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure— Separately inject equal volumes (about 20µL)of the Standard preparationand the Assay preparationinto the chromatograph,record the chromatograms,and measure the responses for the verteporfin peaks.Calculate the quantity,in mg,of C41H42N4O8in the portion of Verteporfin taken by the formula:
100C(rU/rS),
in which Cis the concentration,in mg per mL,of USP Verteporfin RSin theStandard preparation;and rUand rSare the sums of the peak responses of the two verteporfin regioisomer peak responses obtained from the Assay preparationand the Standard preparation,respectively.
Calculate the ratio of the peak responses for the two peaks assigned to verteporfin:not less than 0.9and not more than 1.1.
Auxiliary Information— Staff Liaison:Lawrence Evans,III,Ph.D.,Scientist
Expert Committee:(PA6)Pharmaceutical Analysis 6
USP28–NF23Page 2021
Pharmacopeial Forum:Volume No.30(3)Page 947
Phone Number:1-301-816-8389